The overall annual incidence of cancer varies widely depending on factors such as geographic location, population demographics, lifestyle factors and access to care. According to estimates by the International Agency for Research on Cancer (IARC), approximately 19.3 million new cases of cancer are diagnosed worldwide every year. The most frequently diagnosed cancers worldwide include lung cancer, breast cancer, colorectal cancer, prostate cancer and stomach cancer. However, the specific types of cancer and their incidence rates can vary widely between different regions and populations.
It is important to note that cancer incidence rates may change over time due to a variety of factors, including changes in risk factors, improvements in cancer detection and diagnosis, and the implementation of cancer screening and prevention programmes. For this reason, early diagnosis of cancer is becoming increasingly important because it can improve treatment outcomes and increase the chances of being cured.
Vitro develops, produces and markets a full range of diagnostic products with a focus on quality, accuracy and the ability to improve the efficiency of diagnostic processes.
Vitro provides anatomical pathologists and other healthcare professionals with reliable and effective tools to make accurate assessments and diagnoses, impacting on treatment and clinical management decisions for each patient.